1. Baek, N. I., Kim, D. S., Lee, Y. H., Park, J. D., Lee, C. B. and Kim, S, I., Cytotoxicities of ginseng saponins and their degradation products against some cancer cell lines,Arch. Pharm. Res., 18, 164–168 (1995).
2. Baek, N. I., Kim, D. S., Lee, Y. H., Park, J. D., Lee, C. B. and Kim, S. I., Ginsenoside Rh4, A genuine dammarane glycoside from Korean red ginseng,Planta Med., 62, 86–87 (1996).
3. Chen, Y., Xu, S., Ma, O., Yao, X., Ogihara, Y. and Takeda, T., Minor saponins from the leaves ofPanax ginseng C. A. Meyer,J. Shenyang College of Pharamacy, 4, 282–289 (1987).
4. Kim, D. S., Baek, N. I., Park, J. D., Lee, Y. H., Jeong, S. Y., Lee, C. B. and Kim, S. I., Preparation and structure determination of a new glycoside, (20E)-ginsenoside Rh3 and its isomer from diol-type ginseng saponins,Yakhak Hoeji, 39, 85–93 (1995b).
5. Kim, D.-S., Chang, Y.-J., Zedk, U., Zhao, P., Liu, Y.-Q. and Yang, C.-R., Dammarane saponins fromPanax ginseng, Phytochem., 40, 1493–1497 (1995a).